Key result
Combined glibenclamide and RP 49356 reduces VF by ~75% in isolated ischemic rat hearts.
Why the study?
The role of the ATP-sensitive K+ channel (IK(ATP)) as a target for antifibrillatory intervention in acute myocardial ischaemia was investigated due to unclear antiarrhythmic mechanisms.
Does modulation of the ATP-sensitive K+ channel reduce ischaemia-induced ventricular fibrillation in isolated rat hearts?
RCT (n=32)
blinded
randomised
Does modulation of the ATP-sensitive K+ channel reduce ischaemia-induced ventricular fibrillation in isolated rat hearts?
Absolute Event Rate: 25% vs 100%
p-value: p=< 0.05
In an isolated rat heart model of acute ischaemia, glibenclamide reduced sustained ventricular fibrillation, and its combination with a channel opener paradoxically reduced overall VF incidence.
May guide KATP-targeted antiarrhythmic research in models; leaves open clinical translation.
We tested the hypothesis that blockade of the ATP-sensitive K+ channel (IK(ATP)) is an antiarrhythmic mechanism in acute myocardial ischaemia, using an opener of the channel (10 microM RP 49356, RP) and a blocker of the channel (10 microM glibenclamide, GL) and a combination of the two drugs (GL+RP, 10 microM each) in a randomised blinded study. Isolated rat hearts (n = 8 per group) were subjected to 30-min left regional ischaemia. GL and GL+RP widened QT interval after 10-min ischaemia (197 +/- 39 and 203 +/- 20 ms, respectively vs. 154 +/- 12 ms in controls), whereas RP significantly shortened QT interval (123 +/- 6 ms). GL and GL+RP decreased coronary flow (p < 0.05). RP caused slight increase in flow during ischaemia. These effects are all consistent with modulation of vascular and cardiac IK(ATP). RP alone had no effect on ischaemia-induced arrhythmias. Neither did GL have any effect on the incidence of ventricular fibrillation (VF: 88 vs. 100% in controls). However, GL reduced the incidence of sustained VF (VF lasting continuously for > 2 min) to 14% vs. 88% in controls (p < 0.05). Therefore, GL had defibrillatory activity. Surprisingly, in view of these findings, the GL+RP combination significantly reduced the incidence of VF to 25% (from 100% in control hearts, p < 0.05) i.e., had an antifibrillatory effect. So, two agents that produce pharmacological effects attributable to block and opening of IK(ATP) when administered singly had no effects on the incidence of ischaemia-induced VF.(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Rees et al. (1995) conducted an RCT in acute myocardial ischaemia (n=32). Glibenclamide (GL) + RP 49356 (RP) combination vs. controls was evaluated on incidence of ventricular fibrillation (VF) (p=< 0.05). The combination of glibenclamide and RP 49356 significantly reduced the incidence of ventricular fibrillation to 25% (vs 100% in controls; p<0.05) in isolated rat hearts with acute ischaemia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: